Amicus Therapeutics Announces Settlement of Galafold® ( migalastat ) Patent Litigation with Teva - Amicus Therapeutics ( NASDAQ:FOLD )

Yesterday

PRINCETON, N.J., Oct. 17, 2024 ( GLOBE NEWSWIRE ) -- Amicus Therapeutics FOLD today announced that it has entered into a License Agreement ( Agreement ) with Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc. ( collectively Teva ) .

Ticker	Sentiment	Impact
FOLD	Bullish	44 %